The Food and Drug Administration has granted permission for Juul to continue selling its e-cigarettes, offering some reprieve ...

Marcel Botha discusses whether AI can truly be used to replace laid off human workers at FDA.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Earlier, in January 2025, the FDA released a companion piece of draft guidance titled “Considerations for the Use of ...

Hyperfine (Nasdaq:HYPR) announced that it made the first commercial sales of its next-generation Swoop system powered by new ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

TAVIPILOT Soft is said to be a ‘world-first’ provision for real-time surgical guidance during TAVI and TAVR procedures.

The burden then shifts to hospitals, which puts clinicians in a tough spot, relying on AI that might not generalize, with no ...

AI also supports reverse vaccinology, where pathogen genomes are computationally analyzed to identify immunogenic regions ...

The team spent 14 months investigating and found that the FDA had allowed more than 150 potentially unsafe drugs in the U.S.

As the United States moves beyond the first months of the second Trump Administration, artificial intelligence has emerged as a central focus across multiple areas of the narrowly Republican-contro | ...

The new Tempus software analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with having a low ...